Literature DB >> 19355861

Chalcones derivatives acting as cell cycle blockers: potential anti cancer drugs?

Ahcene Boumendjel1, Xavier Ronot, Jean Boutonnat.   

Abstract

Chalcones (1,3-diphenylpropen-1-ones) are naturally occurring compounds belonging to the flavonoid family and are largely investigated in various therapeutic area and especially as antitumor drugs. In the latter field, the literature survey indicates that effect on the cell cycle is one of the most important targets domains of chalcones. In this review, we will shed light on: a) the structural criteria responsible for the cell cycle perturbations, b) the activity of chalcones on cell cycle molecular players or regulators c) the correlation between the chalcone-structure and proteins involved directly or not in cell cycle regulation and apoptosis by enhancement of proapoptotic molecules expression. We will discuss some perspectives related on how can we deal with chemical modification of chalcones to come up with more potent compounds to provide new ways for cancer treatment.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19355861     DOI: 10.2174/138945009787846416

Source DB:  PubMed          Journal:  Curr Drug Targets        ISSN: 1389-4501            Impact factor:   3.465


  18 in total

1.  Inhibition of mitogen activated protein kinases increases the sensitivity of A549 lung cancer cells to the cytotoxicity induced by a kava chalcone analog.

Authors:  Janel K Warmka; Eric L Solberg; Nicholette A Zeliadt; Balasubramanian Srinivasan; Aaron T Charlson; Chengguo Xing; Elizabeth V Wattenberg
Journal:  Biochem Biophys Res Commun       Date:  2012-07-03       Impact factor: 3.575

Review 2.  Chalcone: A Privileged Structure in Medicinal Chemistry.

Authors:  Chunlin Zhuang; Wen Zhang; Chunquan Sheng; Wannian Zhang; Chengguo Xing; Zhenyuan Miao
Journal:  Chem Rev       Date:  2017-05-10       Impact factor: 60.622

3.  Synthesis and evaluation of indole-based chalcones as inducers of methuosis, a novel type of nonapoptotic cell death.

Authors:  Michael W Robinson; Jean H Overmeyer; Ashley M Young; Paul W Erhardt; William A Maltese
Journal:  J Med Chem       Date:  2012-02-28       Impact factor: 7.446

4.  1,3-diaryl-2-propenones and 2-benzylidene-1,3-indandiones: a quest for compounds displaying greater toxicity to neoplasms than normal cells.

Authors:  Hari N Pati; Umashankar Das; Hiroshi Sakagami; Masame Kawase; Qing Chu; Qintao Wang; James P Stables; Jonathan R Dimmock
Journal:  Arch Pharm (Weinheim)       Date:  2010-09       Impact factor: 3.751

5.  Dual properties of hispidulin: antiproliferative effects on HepG2 cancer cells and selective inhibition of ABCG2 transport activity.

Authors:  Carina T Scoparo; Glaucio Valdameri; Paulo R Worfel; Fernanda A L B Guterres; Glaucia R Martinez; Sheila M B Winnischofer; Attilio Di Pietro; Maria E M Rocha
Journal:  Mol Cell Biochem       Date:  2015-07-26       Impact factor: 3.396

6.  Dynamic residual complexity of the isoliquiritigenin-liquiritigenin interconversion during bioassay.

Authors:  Charlotte Simmler; Atieh Hajirahimkhan; David C Lankin; Judy L Bolton; Tristesse Jones; Djaja D Soejarto; Shao-Nong Chen; Guido F Pauli
Journal:  J Agric Food Chem       Date:  2013-02-22       Impact factor: 5.279

7.  Chalcones enhance TRAIL-induced apoptosis in prostate cancer cells.

Authors:  Ewelina Szliszka; Zenon P Czuba; Bogdan Mazur; Lukasz Sedek; Andrzej Paradysz; Wojciech Krol
Journal:  Int J Mol Sci       Date:  2009-12-24       Impact factor: 5.923

8.  (2E)-2-Benzyl-idene-5,6-dimethoxy-indan-1-one.

Authors:  Mohamed Ashraf Ali; Rusli Ismail; Soo Choon Tan; Chin Sing Yeap; Hoong-Kun Fun
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-09-11

9.  (E)-4-aryl-4-oxo-2-butenoic acid amides, chalcone-aroylacrylic acid chimeras: design, antiproliferative activity and inhibition of tubulin polymerization.

Authors:  Maja D Vitorović-Todorović; Aleksandra Erić-Nikolić; Branka Kolundžija; Ernest Hamel; Slavica Ristić; Ivan O Juranić; Branko J Drakulić
Journal:  Eur J Med Chem       Date:  2013-01-11       Impact factor: 6.514

10.  Pharmacokinetic Studies of Oxathio-Heterocycle Fused Chalcones.

Authors:  Krystyna Okoniewska; Marek T Konieczny; Krzysztof Lemke; Tomasz Grabowski
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-02       Impact factor: 2.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.